Selected research
Industry Growth & Trends
Global Cell Immunotherapy Platform Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Cell Immunotherapy Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Immunotherapy Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Cell Immunotherapy Platform market include Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech and Celltrion, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cell Immunotherapy Platform market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cell Immunotherapy Platform market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cell Immunotherapy Platform market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cell Immunotherapy Platform.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Cell Immunotherapy Platform market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cell Immunotherapy Platform Market by Company
Kite Pharma
Novartis
Bristol Myers Squibb
Gilead Sciences
Bluebird Bio
Celyad Oncology
Autolus Therapeutics
Legend Biotech
Celltrion
Cell Immunotherapy Platform Segment by Type
Autologous Immune Cell Therapy
Allogeneic Immune Cell Therapy
Cell Immunotherapy Platform Segment by Application
Immunotherapy Industry
Biopharmaceutical Industry
Others
Cell Immunotherapy Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Immunotherapy Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Immunotherapy Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Immunotherapy Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Cell Immunotherapy Platform companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Autologous Immune Cell Therapy
- Allogeneic Immune Cell Therapy
Applications
- Immunotherapy Industry
- Biopharmaceutical Industry
- Others
Companies covered
- Kite Pharma
- Novartis
- Bristol Myers Squibb
- Gilead Sciences
- Bluebird Bio
- Celyad Oncology
- Autolus Therapeutics
- Legend Biotech
- Celltrion
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Cell Immunotherapy Platform Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Cell Immunotherapy Platform Market Size by Region (2021-2032)
- 1.4.1 Global Cell Immunotherapy Platform Market Size by Region (2021-2026)
- 1.4.2 Global Cell Immunotherapy Platform Market Size by Region (2027-2032)
- 1.5 Key Regions Cell Immunotherapy Platform Market Size (2021-2032)
- 1.5.1 North America Cell Immunotherapy Platform Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Cell Immunotherapy Platform Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Cell Immunotherapy Platform Market Size Growth Rate (2021-2032)
- 1.5.4 South America Cell Immunotherapy Platform Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Cell Immunotherapy Platform Market Size Growth Rate (2021-2032)
2 Cell Immunotherapy Platform Market by Type
- 2.1 Type Introduction
- 2.1.1 Autologous Immune Cell Therapy
- 2.1.2 Allogeneic Immune Cell Therapy
- 2.2 Global Cell Immunotherapy Platform Market Size by Type
- 2.2.1 Global Cell Immunotherapy Platform Market Size Overview by Type (2021-2032)
- 2.2.2 Global Cell Immunotherapy Platform Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Cell Immunotherapy Platform Market Size Forecasted by Type (2027-2032)
- 2.3 Global Cell Immunotherapy Platform Market Size by Regions
- 2.3.1 North America Cell Immunotherapy Platform Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Cell Immunotherapy Platform Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Cell Immunotherapy Platform Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Cell Immunotherapy Platform Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Cell Immunotherapy Platform Market Size Breakdown by Type (2021-2026)
3 Cell Immunotherapy Platform Market by Application
- 3.1 Type Introduction
- 3.1.1 Immunotherapy Industry
- 3.1.2 Biopharmaceutical Industry
- 3.1.3 Others
- 3.2 Global Cell Immunotherapy Platform Market Size by Application
- 3.2.1 Global Cell Immunotherapy Platform Market Size Overview by Application (2021-2032)
- 3.2.2 Global Cell Immunotherapy Platform Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Cell Immunotherapy Platform Market Size Forecasted by Application (2027-2032)
- 3.3 Global Cell Immunotherapy Platform Market Size by Regions
- 3.3.1 North America Cell Immunotherapy Platform Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Cell Immunotherapy Platform Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Cell Immunotherapy Platform Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Cell Immunotherapy Platform Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Cell Immunotherapy Platform Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Cell Immunotherapy Platform Industry Trends
- 4.2 Cell Immunotherapy Platform Industry Drivers
- 4.3 Cell Immunotherapy Platform Industry Opportunities and Challenges
- 4.4 Cell Immunotherapy Platform Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Cell Immunotherapy Platform Revenue (2021-2026)
- 5.2 Global Cell Immunotherapy Platform Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Cell Immunotherapy Platform Key Company Headquarters & Area Served
- 5.4 Global Cell Immunotherapy Platform Company, Product Type & Application
- 5.5 Global Cell Immunotherapy Platform Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Cell Immunotherapy Platform Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Cell Immunotherapy Platform Players Market Share by Revenue in 2025
- 5.6.3 2025 Cell Immunotherapy Platform Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Kite Pharma
- 6.1.1 Kite Pharma Company Information
- 6.1.2 Kite Pharma Business Overview
- 6.1.3 Kite Pharma Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Kite Pharma Cell Immunotherapy Platform Product Portfolio
- 6.1.5 Kite Pharma Recent Developments
- 6.2 Novartis
- 6.2.1 Novartis Company Information
- 6.2.2 Novartis Business Overview
- 6.2.3 Novartis Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Novartis Cell Immunotherapy Platform Product Portfolio
- 6.2.5 Novartis Recent Developments
- 6.3 Bristol Myers Squibb
- 6.3.1 Bristol Myers Squibb Company Information
- 6.3.2 Bristol Myers Squibb Business Overview
- 6.3.3 Bristol Myers Squibb Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bristol Myers Squibb Cell Immunotherapy Platform Product Portfolio
- 6.3.5 Bristol Myers Squibb Recent Developments
- 6.4 Gilead Sciences
- 6.4.1 Gilead Sciences Company Information
- 6.4.2 Gilead Sciences Business Overview
- 6.4.3 Gilead Sciences Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Gilead Sciences Cell Immunotherapy Platform Product Portfolio
- 6.4.5 Gilead Sciences Recent Developments
- 6.5 Bluebird Bio
- 6.5.1 Bluebird Bio Company Information
- 6.5.2 Bluebird Bio Business Overview
- 6.5.3 Bluebird Bio Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Bluebird Bio Cell Immunotherapy Platform Product Portfolio
- 6.5.5 Bluebird Bio Recent Developments
- 6.6 Celyad Oncology
- 6.6.1 Celyad Oncology Company Information
- 6.6.2 Celyad Oncology Business Overview
- 6.6.3 Celyad Oncology Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Celyad Oncology Cell Immunotherapy Platform Product Portfolio
- 6.6.5 Celyad Oncology Recent Developments
- 6.7 Autolus Therapeutics
- 6.7.1 Autolus Therapeutics Company Information
- 6.7.2 Autolus Therapeutics Business Overview
- 6.7.3 Autolus Therapeutics Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Autolus Therapeutics Cell Immunotherapy Platform Product Portfolio
- 6.7.5 Autolus Therapeutics Recent Developments
- 6.8 Legend Biotech
- 6.8.1 Legend Biotech Company Information
- 6.8.2 Legend Biotech Business Overview
- 6.8.3 Legend Biotech Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Legend Biotech Cell Immunotherapy Platform Product Portfolio
- 6.8.5 Legend Biotech Recent Developments
- 6.9 Celltrion
- 6.9.1 Celltrion Company Information
- 6.9.2 Celltrion Business Overview
- 6.9.3 Celltrion Cell Immunotherapy Platform Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Celltrion Cell Immunotherapy Platform Product Portfolio
- 6.9.5 Celltrion Recent Developments
7 North America
- 7.1 North America Cell Immunotherapy Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 7.3 North America Cell Immunotherapy Platform Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Cell Immunotherapy Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 8.3 Europe Cell Immunotherapy Platform Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Immunotherapy Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Cell Immunotherapy Platform Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Cell Immunotherapy Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 10.3 South America Cell Immunotherapy Platform Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Immunotherapy Platform Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Cell Immunotherapy Platform Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst